AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25378426 — intervention group
Group type: COMPARATOR
Intervention: TMSsub group (subsequent picture-naming activity after primed 1 Hz-rTMS)
Number of subjects: 45
Study 25378426 — intervention group
Group type: COMPARATOR
Intervention: TMSsham group (concurrent naming task with sham 1 Hz-rTMS)
Number of subjects: 45
Study 23213978 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive auricular acupuncture
Number of subjects: 90
Study 23213978 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 90
Study 20662329 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Thriposha (cereal-based food with calcium and vitamin D3)
Number of subjects: 60
Study 20662329 — intervention group
Group type: COMPARATOR
Intervention: Corn-Soya-Blend (CSB) without mineral and vitamin premix
Number of subjects: 60
Study 18309461 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 3
Study 18309461 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol + Enalapril
Number of subjects: 3
Study 18309461 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 3
Study 16042514 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 education sessions using a medical simulator
Number of subjects: 0
Study 16042514 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (no intervention initially)
Number of subjects: 0
Study 12270567 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 100mg
Number of subjects: 116
Study 12270567 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 250mg
Number of subjects: 116
Study 12270567 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 500mg
Number of subjects: 116
Study 12270567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 10602101 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler imaging
Number of subjects: 20
Study 10602101 — intervention group
Group type: EXPERIMENTAL
Intervention: Gray-scale sonography
Number of subjects: 20
Study 15321258 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg diamorphine
Number of subjects: 40
Study 15321258 — intervention group
Group type: COMPARATOR
Intervention: Saline with bupivacaine 0.5% in 8% dextrose (Control)
Number of subjects: 40
Study 8476582 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 400 mg once daily for 7-14 days
Number of subjects: 319
Study 8476582 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin 500 mg twice daily for 7-14 days
Number of subjects: 319
Study 3516258 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoxsuprine
Number of subjects: 10
Study 3516258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29305397 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls Management Exercise (FaME) programme
Number of subjects: 650
Study 28186887 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Singular Value Decomposition (rSVD)
Number of subjects: 2
Study 28186887 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Spatial Downsampling
Number of subjects: 2
Study 28186887 — intervention group
Group type: COMPARATOR
Intervention: Full Singular Value Decomposition (SVD)
Number of subjects: 2
Study 25686857 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (Group S)
Number of subjects: 72
Study 25686857 — intervention group
Group type: COMPARATOR
Intervention: Propofol (Group P)
Number of subjects: 72
Study 23221579 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg DHA and 300 mg EPA supplementation for 6 months
Number of subjects: 172
Study 23221579 — intervention group
Group type: COMPARATOR
Intervention: 2 mL olive oil/d for 6 months (Control)
Number of subjects: 172
Study 21722960 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanocobalamin formulated with 100-mg SNAC (5 mg dose)
Number of subjects: 20
Study 21722960 — intervention group
Group type: COMPARATOR
Intervention: Commercially available 5-mg cyanocobalamin tablet
Number of subjects: 20
Study 21722960 — intervention group
Group type: COMPARATOR
Intervention: Commercially available 1-mg cyanocobalamin IV
Number of subjects: 20
Study 19303160 — intervention group
Group type: EXPERIMENTAL
Intervention: PI-88 (160 mg/day)
Number of subjects: 168
Study 19303160 — intervention group
Group type: EXPERIMENTAL
Intervention: PI-88 (250 mg/day)
Number of subjects: 168
Study 19303160 — intervention group
Group type: COMPARATOR
Intervention: Untreated (Group A)
Number of subjects: 168
Study 17040264 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment 0.1%
Number of subjects: 16
Study 17040264 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone butyrate ointment 1%
Number of subjects: 16
Study 15301646 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenting program
Number of subjects: 157
Study 15301646 — intervention group
Group type: COMPARATOR
Intervention: Literature control condition
Number of subjects: 157
Study 10931801 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg loading dose on day 1, followed by 75 mg/d) plus aspirin (325 mg/d)
Number of subjects: 1020
Study 10931801 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg/d) plus aspirin (325 mg/d)
Number of subjects: 1020
Study 10931801 — intervention group
Group type: COMPARATOR
Intervention: Ticlopidine (250 mg BID) plus aspirin (325 mg/d)
Number of subjects: 1020
Study 10931801 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (Clopidogrel and Ticlopidine)
Number of subjects: 1020
Study 9135351 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% sevoflurane
Number of subjects: 15
Study 9135351 — intervention group
Group type: COMPARATOR
Intervention: 5% halothane
Number of subjects: 15
Study 7963711 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD4‐PE40, 1, 5, 10, or 15 micrograms/kg by intravenous bolus once a month for 2 months, then weekly for 6 weeks.
Number of subjects: 24
Study 7963711 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD4‐PE40, 10 micrograms/kg (maximally tolerated dose).
Number of subjects: 24
Study 7963711 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD4‐PE40.
Number of subjects: 24
Study 3312020 — intervention group
Group type: EXPERIMENTAL
Intervention: Flucloxacillin
Number of subjects: 42
Study 3312020 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin with clavulanic acid
Number of subjects: 42
Study 31900620 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive experience with the oncologist
Number of subjects: 204
Study 31900620 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers’ experience with the oncologist
Number of subjects: 204
Study 30396343 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion therapy with educational video program
Number of subjects: 51
Study 30396343 — intervention group
Group type: COMPARATOR
Intervention: Control group with only educational program
Number of subjects: 51
Study 28205278 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 μg ramosetron
Number of subjects: 409
Study 28205278 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 μg ramosetron
Number of subjects: 409
Study 28205278 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 μg ramosetron
Number of subjects: 409
Study 28205278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 409
Study 26378721 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation emphasizing malleable biology
Number of subjects: 216
Study 26378721 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral psychoeducation
Number of subjects: 216
Study 26378721 — intervention group
Group type: COMPARATOR
Intervention: Biology-only psychoeducation
Number of subjects: 216
Study 22674639 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal cones (VC)
Number of subjects: 45
Study 22674639 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 45
Study 22674639 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 45
Study 21600550 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-alpha-hydroxyprogesterone caproate (17-OHPC)
Number of subjects: 380
Study 21600550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 380
Study 18204339 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol 7.5 mg/d
Number of subjects: 86
Study 18204339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 17063022 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol candies
Number of subjects: 145
Study 17063022 — intervention group
Group type: COMPARATOR
Intervention: Control group (no xylitol candies)
Number of subjects: 145
Study 12639650 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 72
Study 12639650 — intervention group
Group type: EXPERIMENTAL
Intervention: Interstitial laser coagulation (ILC)
Number of subjects: 72
Study 11203848 — intervention group
Group type: EXPERIMENTAL
Intervention: F2000/Z100 sandwich restorations
Number of subjects: 72
Study 11203848 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitremer/Z100 sandwich restorations
Number of subjects: 72
Study 11203848 — intervention group
Group type: COMPARATOR
Intervention: Z100 total-bond restorations
Number of subjects: 72
Study 11203848 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich restorations on contaminated dentin
Number of subjects: 72
Study 11203848 — intervention group
Group type: EXPERIMENTAL
Intervention: All types of restorations
Number of subjects: 72
Study 11203848 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid etching of the dentin
Number of subjects: 72
Study 9347195 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 18
Study 9347195 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 18
Study 9347195 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study 8126146 — intervention group
Group type: COMPARATOR
Intervention: Nal-Glu alone
Number of subjects: 48
Study 8126146 — intervention group
Group type: EXPERIMENTAL
Intervention: Nal-Glu + T 50 mg
Number of subjects: 48
Study 8126146 — intervention group
Group type: EXPERIMENTAL
Intervention: Nal-Glu + T 100 mg
Number of subjects: 48
Study 8126146 — intervention group
Group type: EXPERIMENTAL
Intervention: Nal-Glu + T + Teslac 250 mg
Number of subjects: 48
Study 8126146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 2577498 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ranitidine (300 mg q.d.s.)
Number of subjects: 245
Study 2577498 — intervention group
Group type: COMPARATOR
Intervention: Standard dose ranitidine (300 mg nocte)
Number of subjects: 245
Study 2577498 — intervention group
Group type: COMPARATOR
Intervention: Standard ranitidine therapy
Number of subjects: 245
Study 175669 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-course radiation therapy
Number of subjects: 188
Study 175669 — intervention group
Group type: COMPARATOR
Intervention: Continuous radiation therapy
Number of subjects: 188
Study 31180620 — intervention group
Group type: EXPERIMENTAL
Intervention: Active repetitive transcranial magnetic stimulation
Number of subjects: 18
Study 31180620 — intervention group
Group type: COMPARATOR
Intervention: Sham repetitive transcranial magnetic stimulation (Control)
Number of subjects: 18
Study 27771761 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping skills training for junior gynecologists (12 weekly sessions over 3 months)
Number of subjects: 78
Study 27771761 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 78
Study 25757039 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (52 weeks)
Number of subjects: 126
Study 24176893 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise at least once per week for 6 months
Number of subjects: 104
Study 24176893 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular training group (n = 27)
Number of subjects: 104
Study 24176893 — intervention group
Group type: EXPERIMENTAL
Intervention: Irregular training group (n = 33)
Number of subjects: 104
Study 22769971 — intervention group
Group type: EXPERIMENTAL
Intervention: Well London program (community engagement intervention)
Number of subjects: 5321
Study 22769971 — intervention group
Group type: COMPARATOR
Intervention: Control communities (matched neighborhoods)
Number of subjects: 5321
Study 19382463 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanreqing Injection (20 mL) with 5% G/NS (500 mL) once a day for two weeks
Number of subjects: 87
Study 19382463 — intervention group
Group type: COMPARATOR
Intervention: Yanhuning injection (0.4 g) with 5% G/NS (500 mL) once a day for two weeks
Number of subjects: 87
Study 17718364 — intervention group
Group type: EXPERIMENTAL
Intervention: Centred egocentric condition
Number of subjects: 0
Study 17718364 — intervention group
Group type: COMPARATOR
Intervention: Allocentric condition
Number of subjects: 0
Study 17718364 — intervention group
Group type: EXPERIMENTAL
Intervention: Decentred egocentric condition
Number of subjects: 0
Study 15615744 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodide iontophoresis
Number of subjects: 28
Study 15615744 — intervention group
Group type: COMPARATOR
Intervention: Iodide application without current
Number of subjects: 28
Study 11952025 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated fluoxetine 90 mg on both days (LPWDx2)
Number of subjects: 257
Study 11952025 — intervention group
Group type: COMPARATOR
Intervention: Placebo on both days (PLC)
Number of subjects: 257
Study 11952025 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo 14 days before menses and enteric-coated fluoxetine 90 mg 7 days before menses (LPWDx1)
Number of subjects: 257
Study 9812081 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 30
Study 9812081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 8950297 — intervention group
Group type: EXPERIMENTAL
Intervention: RU486 (mifepristone)
Number of subjects: 8
Study 8950297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 8950297 — intervention group
Group type: COMPARATOR
Intervention: Spironolactone 200mg
Number of subjects: 8
Study 1771220 — intervention group
Group type: COMPARATOR
Intervention: Glucose 0 g (Control)
Number of subjects: 0
Study 1771220 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose 30 g
Number of subjects: 0
Study 1771220 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose 100 g
Number of subjects: 0
Study 6941444 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole 2 g (single oral dose, pre-operatively)
Number of subjects: 210
Study 6941444 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 210
Study 31402028 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine bathing
Number of subjects: 0
Study 31402028 — intervention group
Group type: COMPARATOR
Intervention: Routine bathing
Number of subjects: 0
Study 28061017 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 51
Study 28061017 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 51
Study 26476610 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 720
Study 23469080 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum CXCL5 levels
Number of subjects: 290
Study 23469080 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic score model (C-C model) based on sCXCL5 levels and clinical classification
Number of subjects: 290
Study 21789509 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision sleeve gastrectomy
Number of subjects: 50
Study 21789509 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic sleeve gastrectomy
Number of subjects: 50
Study 19116328 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet protocol (n = 45)
Number of subjects: 187
Study 19116328 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise protocol (n = 48)
Number of subjects: 187
Study 19116328 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus exercise protocol (n = 58)
Number of subjects: 187
Study 19116328 — intervention group
Group type: COMPARATOR
Intervention: Control protocol (n = 36)
Number of subjects: 187
Study 19116328 — intervention group
Group type: EXPERIMENTAL
Intervention: All intervention groups
Number of subjects: 187
Study 16274980 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol 160/4.5 microg in a single inhaler
Number of subjects: 339
Study 16274980 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate 250 microg
Number of subjects: 339
Study 15229417 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent endoscopy
Number of subjects: 93
Study 15229417 — intervention group
Group type: COMPARATOR
Intervention: Elective endoscopy
Number of subjects: 93
Study 15229417 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient care recommendation
Number of subjects: 93
Study 11085351 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinin
Number of subjects: 0
Study 11085351 — intervention group
Group type: EXPERIMENTAL
Intervention: Desferrioxamine
Number of subjects: 0
Study 11085351 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study 1496226 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy following lumpectomy
Number of subjects: 0
Study 1496226 — intervention group
Group type: COMPARATOR
Intervention: No radiation therapy following lumpectomy
Number of subjects: 0
Study 1496226 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic therapy following IBTR
Number of subjects: 0
Study 1496226 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy with and without breast irradiation
Number of subjects: 0
Study 6196251 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenine arabinoside monophosphate (10 patients)
Number of subjects: 20
Study 6196251 — intervention group
Group type: COMPARATOR
Intervention: No treatment (10 patients)
Number of subjects: 20
Study 31783827 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support worker (PSW+)
Number of subjects: 0
Study 31783827 — intervention group
Group type: COMPARATOR
Intervention: Standard care (PSW‐)
Number of subjects: 0
Study 29565776 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Oriented Recovery Enhancement (MORE)
Number of subjects: 30
Study 29565776 — intervention group
Group type: COMPARATOR
Intervention: Support Group (SG)
Number of subjects: 30
Study 26882332 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral parent training (8 group sessions) and brief teacher consultation to establish a Daily Report Card
Number of subjects: 146
Study 26882332 — intervention group
Group type: COMPARATOR
Intervention: Extended‐release methylphenidate (equivalent to .15 mg/kg/dose bid)
Number of subjects: 146
Study 26882332 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral parent training
Number of subjects: 146
Study 26882332 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial behavior modification
Number of subjects: 146
Study 25030943 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 75 mg intramuscularly immediately after ERCP
Number of subjects: 120
Study 25030943 — intervention group
Group type: COMPARATOR
Intervention: Control group (no diclofenac)
Number of subjects: 120
Study 25030943 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac group
Number of subjects: 120
Study 23290323 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinated Anxiety Learning and Management (CALM)
Number of subjects: 1004
Study 23290323 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1004
Study 20927492 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training (CG)
Number of subjects: 50
Study 18823986 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib (60 or 90 mg qd)
Number of subjects: 34701
Study 18823986 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac (150 mg qd)
Number of subjects: 34701
Study 18823986 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 34701
Study 18823986 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 34701
Study 18823986 — intervention group
Group type: COMPARATOR
Intervention: Etoricoxib vs Diclofenac
Number of subjects: 34701
Study 16505756 — intervention group
Group type: EXPERIMENTAL
Intervention: LV5FU2‐irinotecan
Number of subjects: 134
Study 16505756 — intervention group
Group type: COMPARATOR
Intervention: LV5FU2‐cisplatin
Number of subjects: 134
Study 16505756 — intervention group
Group type: COMPARATOR
Intervention: LV5FU2 alone
Number of subjects: 134
Study 12598340 — intervention group
Group type: EXPERIMENTAL
Intervention: S16020 (80 or 100 mg/m2, 3‐h infusion every 3 weeks)
Number of subjects: 36
Study 12598340 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (40 or 50 mg/m2, bolus injection weekly for a minimum of 6 weeks)
Number of subjects: 36
Study 12598340 — intervention group
Group type: EXPERIMENTAL
Intervention: S16020
Number of subjects: 36
Study 12598340 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 36
Study 10583282 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy during the first 18 hours of admission
Number of subjects: 120
Study 10583282 — intervention group
Group type: COMPARATOR
Intervention: Close observation, conventional investigation, and surgical intervention if signs of peritonism developed
Number of subjects: 120
Study 8739138 — intervention group
Group type: EXPERIMENTAL
Intervention: Local antifungal agent (miconazole, 2% gel) for 4 weeks
Number of subjects: 49
Study 8739138 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic antifungal agent (fluconazole, 50 mg) for 2 weeks
Number of subjects: 49
Study 8739138 — intervention group
Group type: COMPARATOR
Intervention: Control group (new complete dentures)
Number of subjects: 49
Study 1934940 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced expirations (manoeuvre A)
Number of subjects: 16
Study 1934940 — intervention group
Group type: COMPARATOR
Intervention: Forced inspirations and slow expirations (manoeuvre B)
Number of subjects: 16
Study 1934940 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mucociliary clearance
Number of subjects: 16
Study 6240764 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide
Number of subjects: 0